Stig B. Holmberg

3.2k citations

51 papers · 2.3k indexed · h-index 20

Impact in

Cancer Research top 1%
- Breast Cancer Treatment Studies
Oncology top 2%
- HER2/EGFR in Cancer Research
- Cancer Risks and Factors
- Cancer Treatment and Pharmacology
- Lung Cancer Research Studies

Papers in

Cancer Research 25
- Breast Cancer Treatment Studies 24
Hepatology 9

Co-authors: Aron Goldhirsch Richard D. Gelber Monica Castiglione‐Gertsch Alan S. Coates Karen N. Price Beat Thürlimann Jurij Lindtner Diana Crivellari
Journals: Journal of Clinical Oncology (12 papers)Breast Cancer Research and Treatment (5 papers)Annals of Oncology (4 papers)Acta Oncologica (3 papers)Cancer (2 papers)
Partner nations: Sweden Switzerland Italy

In The Last Decade

Stig B. Holmberg

50 papers receiving 2.2k citations

Peers

Countries citing papers authored by Stig B. Holmberg

Since Specialization

Citations

This map shows the geographic impact of Stig B. Holmberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stig B. Holmberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stig B. Holmberg more than expected).

Fields of papers citing papers by Stig B. Holmberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stig B. Holmberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stig B. Holmberg. The network helps show where Stig B. Holmberg may publish in the future.

Co-authors

The 25 scholars most cited alongside Stig B. Holmberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stig B. Holmberg Line = papers co-authored together Stig B. Holmberg links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A randomised study of tailored toxicity-based dosage of fluorouracil-epirubicin-cyclophosphamide chemotherapy for early breast cancer (SBG 2000-1) European Journal of Cancer ·Henrik Lindman, Michael Andersson, Johan Ahlgren, Eva Balslev, Ásgerður Sverrisdóttir, Stig B. Holmberg, Nils‐Olof Bengtsson, Прохорова Наталья Юрьевна, Anders Bonde Jensen, Jean M. Hansen, Malgorzata Tuxen, Lena Malmberg, Kenneth Villman, H. Anderson, Bent Ejlertsen, Jonas Bergh, Carl Blomqvist	2018	4
2	Mindfulness based stress reduction study design of a longitudinal randomized controlled complementary intervention in women with breast cancer BMC Complementary and Alternative Medicine ·Elisabeth Kenne Sarenmalm, Lena Mårtensson, Stig B. Holmberg, Bengt Åndersson, Anders Odén, Ingrid Bergh	2013	14
3	Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer Annals of Oncology ·Guenther Gruber, Bernard F. Cole, Monica Castiglione‐Gertsch, Stig B. Holmberg, Jurij Lindtner, Rastko Golouh, J. Collins, Diana Crivellari, Beat Thürlimann, Edda Simoncini, Martin F. Fey, Richard D. Gelber, Alan S. Coates, Karen N. Price, Aron Goldhirsch, Giuseppe Viale, B.A. Gusterson	2008	26
4	Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93 Breast Cancer Research and Treatment ·Beat Thürlimann, Karen N. Price, Richard D. Gelber, Stig B. Holmberg, Diana Crivellari, Marco Colleoni, John P. Collins, John Forbes, Monica Castiglione‐Gertsch, Alan S. Coates, Aron Goldhirsch	2008	45
5	Anemia during adjuvant non-taxane chemotherapy for early breast cancer: Incidence and risk factors from two trials of the International Breast Cancer Study Group Supportive Care in Cancer ·Lorenzo Gianni, Bernard F. Cole, Ilaria Panzini, Raymond Snyder, Stig B. Holmberg, Michael Byrne, Diana Crivellari, Marco Colleoni, Stefan Aebi, Edda Simoncini, Olivia Pagani, Monica Castiglione‐Gertsch, Karen N. Price, Aron Goldhirsch, Alan S. Coates, Alberto Ravaioli	2007	12
6	Cost-effectiveness of exemestane versus tamoxifen as adjuvant therapy for early-stage breast cancer after 2–3 years treatment with tamoxifen in Sweden Breast Cancer Research and Treatment ·Jonas Lundkvist, Nils Wilking, Stig B. Holmberg, Linus Jönsson	2006	19
7	Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG) Annals of Oncology ·Bernhard C. Pestalozzi, David Zahrieh, Karen N. Price, Stig B. Holmberg, Jurij Lindtner, John P. Collins, Diana Crivellari, Martin F. Fey, Elizabeth Murray, Olivia Pagani, Edda Simoncini, Monica Castiglione‐Gertsch, Richard D. Gelber, Alan S. Coates, Aron Goldhirsch	2006	318
8	Randomized Trial Comparing Axillary Clearance Versus No Axillary Clearance in Older Patients With Breast Cancer: First Results of International Breast Cancer Study Group Trial 10-93 Journal of Clinical Oncology ·(unknown), Carl‐Magnus Rudenstam, David Zahrieh, John Forbes, Diana Crivellari, Stig B. Holmberg, Piercarlo Rey, D M Dent, Ian Campbell, Jürg Bernhard, Karen N. Price, Monica Castiglione‐Gertsch, Aron Goldhirsch, Richard D. Gelber	2005	297
9	Timing of CMF chemotherapy in combination with tamoxifen in postmenopausal women with breast cancer: role of endocrine responsiveness of the tumor Annals of Oncology ·Marco Colleoni, Tung-Tien Sunii, Richard D. Gelber, Alan S. Coates, Monica Castiglione‐Gertsch, Karen N. Price, J. Lindtner, C.-M. Rudenstam, Diana Crivellari, J. Collins, Olivia Pagani, Edda Simoncini, Beat Thürlimann, Elizabeth Murray, John Forbes, H. J. Peng, Stig B. Holmberg, Andrea Veronesi, Aron Goldhirsch	2005	16
10	Duration of adjuvant chemotherapy for breast cancer: a joint analysis of two randomised trials investigating three versus six courses of CMF British Journal of Cancer ·(unknown), Marco Colleoni, Heather J. Litman, Monica Castiglione‐Gertsch, Willi Sauerbrei, Richard D. Gelber, Marco Bonetti, Alan S. Coates, Martin Schumacher, G. Bastert, C.-M. Rudenstam, Claudia Schmoor, J. Lindtner, J. Collins, Beat Thürlimann, Stig B. Holmberg, Diana Crivellari, Xibing Jiang, K Kapronczay, Aron Goldhirsch	2002	53
11	Early Start of Adjuvant Chemotherapy May Improve Treatment Outcome for Premenopausal Breast Cancer Patients With Tumors not Expressing Estrogen Receptors Journal of Clinical Oncology ·Marco Colleoni, Marco Bonetti, Alan S. Coates, Monica Castiglione‐Gertsch, Richard D. Gelber, Karen N. Price, Sibel Erdoğan, Jurij Lindtner, John P. Collins, Beat Thürlimann, Stig B. Holmberg, Andrea Veronesi, Giovanni Marini, Aron Goldhirsch, (unknown)	2000	158
12	Influence of zymosan (a non-specific macrophage stimulator) and of indomethacin on liver tumours?an experimental study in rats Journal of Cancer Research and Clinical Oncology ·Stig B. Holmberg, Peter Naredi, Alfredo Herrera-González, Ingvar Karlberg, Peter Daneryd, Joyce Assis Ribeiro, A. Pettersson, Unne Stenram, Hongyan Liu	1995	3
13	Isolated hyperthermic liver perfusion with chemotherapy for liver malignancy Surgical Oncology ·Larsolof Hafström, Stig B. Holmberg, Peter Naredi, Per Lindnér, Anders Bengtsson, Ufuk ISTANBUL TECHNICAL UNIVERSITY CEBECI, T. Scherstén	1994	63
14	Treatment of liver metastases from colorectal cancer with hepatic artery occlusion, intraportal 5-fluorouracil infusion, and oral allopurinol. A randomized clinical trial Cancer ·Larsolof Hafström, Boel Engarås, Stig B. Holmberg, Bengt Gustavsson, Per‐Ebbe Jönsson, Per Lindnér, Peter Naredi, Ufuk ISTANBUL TECHNICAL UNIVERSITY CEBECI	1994	26
15	Therapy with 125I-labelled internalized and non-internalized monoclonal antibodies in nude mice with human colon carcinoma xenografts Nuclear Medicine and Biology ·Eva Forssell‐Aronsson, A W Marino, Lars Jacobsson, Tom Bäck, S. Hertzman, Sture Lindegren, Börje W. Karlsson, Leif Lindholm, Stig B. Holmberg, Larsolof Hafström, Sören Mattsson	1993	6
16	The effects of tumour necrosis factor alpha on the vascular bed and blood flow in an experimental rat hepatoma International Journal of Cancer ·Peter Naredi, Per Lindnér, Stig B. Holmberg, Unne Stenram, Anders Peterson, Larsolof Hafström	1993	17
17	Comparison of the biodistribution of 75Se- and 131I-labelled monoclonal antibodies in nude mice International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology ·A W Marino, Eva Forssell‐Aronsson, Lars Jacobsson, Nathalie Stockborn, Stig B. Holmberg, Larsolof Hafström, Sture Lindegren, Börje W. Karlsson, Leif Lindholm, Sören Mattsson	1992	1
18	Vascular clearance by the reticuloendothelial system—measurements using two different-sized albumin colloids Scandinavian Journal of Clinical and Laboratory Investigation ·Stig B. Holmberg, Eva Forssell‐Aronsson, A W Marino, Lars Jacobsson, Bengt Rippe	1990	10
19	RES function and tumour take and tumour growth in the liver and in the kidney—An experimental study in rats European Journal of Cancer and Clinical Oncology ·Stig B. Holmberg, Larsolof Hafström, U Maaß	1987	5
20	Phagocytosis and dynamic RES scintigraphy Nuclear Medicine Communications ·Stig B. Holmberg, Larsolof Hafström, Lars Jacobsson	1987	9

About Stig B. Holmberg

Stig B. Holmberg is a scholar working on Cancer Research, Hepatology, Oncology, Pathology and Forensic Medicine and Genetics, having authored 51 papers that have together received 2.3k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (24 papers), Estrogen and related hormone effects (10 papers), Cancer Treatment and Pharmacology (7 papers), HER2/EGFR in Cancer Research (6 papers), Breast Lesions and Carcinomas (6 papers), Organ Transplantation Techniques and Outcomes (5 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Cancer Risks and Factors (4 papers). The work is most often cited by research in Cancer Research (1.3k citations), Oncology (1.4k citations), Pathology and Forensic Medicine (718 citations), Pulmonary and Respiratory Medicine (564 citations) and Hepatology (84 citations). Stig B. Holmberg has collaborated with scholars based in Sweden, Switzerland and Italy. Frequent co-authors include Aron Goldhirsch, Richard D. Gelber, Monica Castiglione‐Gertsch, Alan S. Coates, Karen N. Price, Beat Thürlimann, Jurij Lindtner, Diana Crivellari, David Zahrieh and Martin F. Fey. Their work appears in journals such as Journal of Clinical Oncology, Breast Cancer Research and Treatment, Annals of Oncology, Acta Oncologica and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact